Stock 688247 SINOTHERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Sinotherapeutics Inc.

Equities

688247

CNE100005PL9

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-06-02 EDT 		5-day change 1st Jan Change
8.9 CNY -2.20% Intraday chart for Sinotherapeutics Inc. -1.22% -18.94%
04-29 Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-02 Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024. CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024.
CI
Sinotherapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sinotherapeutics Inc. announces an Equity Buyback for CNY 70 million worth of its shares.
CI
Sinotherapeutics Inc. authorizes a Buyback Plan.
CI
Sinotherapeutics Gets Nod for Mesalazine Tablets; Shares Drop 7%
MT
Sinotherapeutics Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Sinotherapeutics' Unit Gets Registration Certificate for Sevelamer Carbonate Tablets
MT
Sinotherapeutics Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Sinotherapeutics Inc.(SHSE:688247) added to Shanghai Stock Exchange A Share Index
CI
Sinotherapeutics Inc.(SHSE:688247) added to Shanghai Stock Exchange Composite Index
CI
Sinotherapeutics Gets US FDA Nod for Arthritis Drug
MT
Sinotherapeutics Signs Product Licensing Deal With US Drugmaker Lannett
MT
FDA Greenlights Sinotherapeutics' Mesalazine Enteric-Coated Tablets
MT
Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Sinotherapeutics Drug Selected in China's Centralized Drug Procurement
MT
Sinotherapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Sinotherapeutics’ Antifungal Drug Added to China’s Medical Insurance Catalog
MT
Sinotherapeutics Inc. has completed an IPO in the amount of CNY 424.8358 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688247 Stock
  4. News Sinotherapeutics Inc.